FIELD: medicine.
SUBSTANCE: invention refers to medicine, and concerns a method for predicting outcomes of COVID-19. Blood is taken and the following levels are determined by flow cytofluorimetry: reaction of blast transformation of lymphocytes (RBTL), marker of natural killers (CD16+) and percentage of lymphocytes (lf), %. Thereafter, the outcome of COVID-19 is assessed by the formula for calculating y: if the value y is equal to 0–0.5, recovery is predicted, if the value y is more than 0.5, a lethal outcome is predicted.
EFFECT: invention provides the possibility of extending the tools for predicting the outcome of COVID-19, which enables to divide patients into two groups: with recovery and with a fatal outcome by determining three parameters of immunity before the beginning of therapy: RBTL, CD16+, lf, %.
1 cl, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE OCCURRENCE OF ACUTE KIDNEY INJURY IN COVID-19-ASSOCIATED PNEUMONIA BASED ON THE LEVEL OF s-CysC | 2022 |
|
RU2788298C2 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH CYTOKINE STORM ASSOCIATED WITH COVID-19 | 2022 |
|
RU2825710C2 |
| METHOD FOR ASSESSING UNFAVORABLE OUTCOME OF SEVERE PNEUMONIA ASSOCIATED WITH COVID-19 BY u-CysC LEVEL | 2022 |
|
RU2779579C2 |
| METHOD FOR ASSESSING UNFAVORABLE OUTCOME OF SEVERE PNEUMONIA ASSOCIATED WITH COVID-19 BY s-CysC LEVEL | 2022 |
|
RU2779581C2 |
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN SARS-CoV-2-ASSOCIATED PNEUMONIA | 2023 |
|
RU2825705C1 |
| METHOD FOR PREDICTING RISK OF DEATH IN HOSPITALIZED PATIENTS WITH COVID-19 RECEIVING RENAL REPLACEMENT THERAPY WITH PROGRAMMED HAEMODIALYSIS FOR STAGE 5 CHRONIC KIDNEY DISEASE | 2024 |
|
RU2829424C1 |
| METHOD OF PREDICTING PRETERM LABOR IN WOMEN WITH PNEUMONIA IN THE THIRD TRIMESTER CAUSED BY SARS-CoV-2 | 2023 |
|
RU2801031C1 |
| METHOD FOR PREDICTING RISK OF DEATH AT HOSPITAL STAGE IN PATIENTS WITHOUT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WHO HAVE UNDERGONE NEW COVID-19 CORONAVIRUS INFECTION, TAKING INTO ACCOUNT THEIR IMMUNOLOGICAL STATUS | 2022 |
|
RU2781565C1 |
| METHOD OF PREDICTING COMPLICATIONS AFTER COVID-19 IN PERSONS WITH COMORBID BACKGROUND IN THE ARCTIC REGION | 2023 |
|
RU2812780C1 |
